Hu, S., Liang, S., Guo, H., Zhang, D., Li, H., Wang, X., . . . Lou, Z. (2013). Comparison of the Inhibition Mechanisms of Adalimumab and Infliximab in Treating Tumor Necrosis Factor α-Associated Diseases from a Molecular View. American Society for Biochemistry and Molecular Biology.
Παραπομπή Chicago StyleHu, Shi, et al. Comparison of the Inhibition Mechanisms of Adalimumab and Infliximab in Treating Tumor Necrosis Factor α-Associated Diseases From a Molecular View. American Society for Biochemistry and Molecular Biology, 2013.
Παραπομπή MLAHu, Shi, et al. Comparison of the Inhibition Mechanisms of Adalimumab and Infliximab in Treating Tumor Necrosis Factor α-Associated Diseases From a Molecular View. American Society for Biochemistry and Molecular Biology, 2013.